Product identification in the medical and healthcare sector is both time-consuming and exacting. Matrix Healthcare Solutions (MHS) attempts to alleviate this process by identifying products suitable for divestment or disposal. The team seeks to accomplish this by acquiring brands and products that are no longer a priority for so-called ‘Big Pharma’ organizations: products that have become problem children, or unloved assets.

The MHS team have a proven capability of working with experts in divestment to ensure reputation, supply, and relationships are maintained and enhanced. Product identification is only the first step. The following steps concern maintaining the integrity of long-term relationships, to guarantee a true understanding of the drive factors and expectations of all stakeholders. This minimizes wastage and expensive resource utilization.

If you need any more information about the MHS team’s experience in product identification, simply contact us today.